Literature DB >> 3125485

Effects of a new TRH analogue, YM-14673 on the central nervous system.

M Yamamoto1, M Shimizu.   

Abstract

The effects of a new TRH analogue, YM-14673 (N alpha-[[S)-4-oxo-2-azetidinyl)carbonyl]-L-histidyl-L-prolinamide dihydrate) on the central nervous system were compared with those of TRH. YM-14673 was 10-40 times more potent than TRH in antagonizing pentobarbital-induced sleep and hypothermia, and ethanol-induced hypothermia in mice. YM-14673 accelerated recovery from disturbed consciousness induced by concussive head trauma in mice and normalized the behavior and spontaneous EEG disturbed by electrolytic lesion of the hypothalamus in cats with 25-100 times greater potency than that of TRH. In the tests on pentobarbital sleeping time and EEG disturbance, the cerebral activating activity of YM-14673 was 8-36 times longer-lasting than that of TRH. These results indicate that YM-14673 possesses potent arousal effects on the central nervous system. The mode of action of YM-14673 was also discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3125485     DOI: 10.1007/bf00169314

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  On the neuropharmacology of thyrotropin releasing hormone (TRH).

Authors:  G G Yarbrough
Journal:  Prog Neurobiol       Date:  1979       Impact factor: 11.685

2.  Effects of thyrotropin-releasing hormone in depression.

Authors:  A J Prange; P P Lara; I C Wilson; L B Alltop; G R Breese
Journal:  Lancet       Date:  1972-11-11       Impact factor: 79.321

3.  Effect of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration.

Authors:  I Sobue; H Yamamoto; M Konagaya; M Iida; T Takayanagi
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321

4.  Biologically stable analogues of TRH with increased neuropharmacological potency.

Authors:  D Brewster; P W Dettmar; G Metcalf
Journal:  Neuropharmacology       Date:  1981-05       Impact factor: 5.250

5.  Cerebral activating properties of indeloxazine hydrochloride.

Authors:  M Yamamoto; M Shimizu
Journal:  Neuropharmacology       Date:  1987-07       Impact factor: 5.250

6.  Neuropeptides in spinal cord injury: comparative experimental models.

Authors:  A I Faden; T P Jacobs; G P Smith; B Green; J A Zivin
Journal:  Peptides       Date:  1983 Sep-Oct       Impact factor: 3.750

7.  Thyrotropin-releasing hormone: evidence for thyroid response to intravenous injection in man.

Authors:  C S Hollander; T Mitsuma; L Shenkman; P Woolf; M C Gershengorn
Journal:  Science       Date:  1972-01-14       Impact factor: 47.728

8.  Thyrotropin-releasing hormone (TRH) analogues show enhanced CNS selectivity because of increased biological stability.

Authors:  G Metcalf; P W Dettmar; A G Lynn; D Brewster; M E Havler
Journal:  Regul Pept       Date:  1981-09

9.  Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone.

Authors:  W K Engel; T Siddique; J T Nicoloff
Journal:  Lancet       Date:  1983-07-09       Impact factor: 79.321

Review 10.  Regulatory peptides as a source of new drugs--the clinical prospects for analogues of TRH which are resistant to metabolic degradation.

Authors:  G Metcalf
Journal:  Brain Res       Date:  1982-11       Impact factor: 3.252

View more
  6 in total

1.  Metabolism of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue, by intestinal microorganisms.

Authors:  I Sasaki; T Tamura; T Shibakawa; T Fujita; M Murakami; A Yamamoto; S Muranishi
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

2.  Nasal absorption kinetic behavior of azetirelin and its enhancement by acylcarnitines in rats.

Authors:  S Kagatani; N Inaba; M Fukui; T Sonobe
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

3.  Effects of a new TRH analogue, YM-14673 on a passive avoidance test as a possible criterion of improvement in cognitive disturbance in rodents.

Authors:  M Yamamoto; M Shimizu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-09       Impact factor: 3.000

4.  Antagonizing effects of YM-14673, a new TRH derivative, on behavioral and electroencephalographic changes in reserpinized animals.

Authors:  M Yamamoto; M Shimizu; A Iwai
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 5.  The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?

Authors:  Jean-Louis Charli; Adair Rodríguez-Rodríguez; Karina Hernández-Ortega; Antonieta Cote-Vélez; Rosa María Uribe; Lorraine Jaimes-Hoy; Patricia Joseph-Bravo
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

6.  Predicted Biological Activity of Purchasable Chemical Space.

Authors:  John J Irwin; Garrett Gaskins; Teague Sterling; Michael M Mysinger; Michael J Keiser
Journal:  J Chem Inf Model       Date:  2017-12-29       Impact factor: 4.956

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.